Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1681901rdf:typepubmed:Citationlld:pubmed
pubmed-article:1681901lifeskim:mentionsumls-concept:C0006784lld:lifeskim
pubmed-article:1681901lifeskim:mentionsumls-concept:C0030946lld:lifeskim
pubmed-article:1681901lifeskim:mentionsumls-concept:C0041491lld:lifeskim
pubmed-article:1681901lifeskim:mentionsumls-concept:C0597304lld:lifeskim
pubmed-article:1681901lifeskim:mentionsumls-concept:C0439801lld:lifeskim
pubmed-article:1681901lifeskim:mentionsumls-concept:C2825492lld:lifeskim
pubmed-article:1681901lifeskim:mentionsumls-concept:C1882074lld:lifeskim
pubmed-article:1681901lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:1681901pubmed:issue43lld:pubmed
pubmed-article:1681901pubmed:dateCreated1991-12-2lld:pubmed
pubmed-article:1681901pubmed:abstractTextLimited proteolysis of tyrosine hydroxylase (TH) by calpain, Ca(2+)-activated neutral protease, was studied. Cleavage of TH with calpain in vitro produced molecules having Mrs of approximately 57,000 and 56,000 in SDS-polyacrylamide gel electrophoresis. The N-terminal amino acid sequence, Ser-Pro-Arg-Phe-Val, of the 56-kDa species indicated that calpain cleaved off the N-terminal region (residues 1-30) encoded by the first exon including Ser-8 and Ser-19, the phosphorylation sites by proline-directed protein kinase (PDPK) and by Ca2+/calmodulin-dependent protein kinase II (kinase II), respectively, from the native TH. The removal of the N-terminal region from the native molecule induced a slight but significant activation of TH at pH 7.0. The native TH behaved as the tetramer with an Mr of 240,000. In contrast, calpain-cleaved TH showed the monomeric Mr by gel permeation chromatography and increased Ki for catecholamine which inhibits the native TH in competition to the coenzyme, DL-6-methyl-5,6,7,8-tetrahydropterin (6MPH4). These results imply that calpain cleavage would effectively release TH from the feedback inhibition by removal of the N-terminal region resulting in disruption of the quaternary structure.lld:pubmed
pubmed-article:1681901pubmed:languageenglld:pubmed
pubmed-article:1681901pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1681901pubmed:citationSubsetIMlld:pubmed
pubmed-article:1681901pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1681901pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1681901pubmed:statusMEDLINElld:pubmed
pubmed-article:1681901pubmed:monthOctlld:pubmed
pubmed-article:1681901pubmed:issn0006-2960lld:pubmed
pubmed-article:1681901pubmed:authorpubmed-author:SuzukiKKlld:pubmed
pubmed-article:1681901pubmed:authorpubmed-author:NagatsuTTlld:pubmed
pubmed-article:1681901pubmed:authorpubmed-author:FujitaKKlld:pubmed
pubmed-article:1681901pubmed:authorpubmed-author:TitaniKKlld:pubmed
pubmed-article:1681901pubmed:authorpubmed-author:KiuchiKKlld:pubmed
pubmed-article:1681901pubmed:issnTypePrintlld:pubmed
pubmed-article:1681901pubmed:day29lld:pubmed
pubmed-article:1681901pubmed:volume30lld:pubmed
pubmed-article:1681901pubmed:ownerNLMlld:pubmed
pubmed-article:1681901pubmed:authorsCompleteYlld:pubmed
pubmed-article:1681901pubmed:pagination10416-9lld:pubmed
pubmed-article:1681901pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1681901pubmed:meshHeadingpubmed-meshheading:1681901-...lld:pubmed
pubmed-article:1681901pubmed:meshHeadingpubmed-meshheading:1681901-...lld:pubmed
pubmed-article:1681901pubmed:meshHeadingpubmed-meshheading:1681901-...lld:pubmed
pubmed-article:1681901pubmed:meshHeadingpubmed-meshheading:1681901-...lld:pubmed
pubmed-article:1681901pubmed:meshHeadingpubmed-meshheading:1681901-...lld:pubmed
pubmed-article:1681901pubmed:meshHeadingpubmed-meshheading:1681901-...lld:pubmed
pubmed-article:1681901pubmed:meshHeadingpubmed-meshheading:1681901-...lld:pubmed
pubmed-article:1681901pubmed:meshHeadingpubmed-meshheading:1681901-...lld:pubmed
pubmed-article:1681901pubmed:meshHeadingpubmed-meshheading:1681901-...lld:pubmed
pubmed-article:1681901pubmed:meshHeadingpubmed-meshheading:1681901-...lld:pubmed
pubmed-article:1681901pubmed:meshHeadingpubmed-meshheading:1681901-...lld:pubmed
pubmed-article:1681901pubmed:meshHeadingpubmed-meshheading:1681901-...lld:pubmed
pubmed-article:1681901pubmed:meshHeadingpubmed-meshheading:1681901-...lld:pubmed
pubmed-article:1681901pubmed:meshHeadingpubmed-meshheading:1681901-...lld:pubmed
pubmed-article:1681901pubmed:year1991lld:pubmed
pubmed-article:1681901pubmed:articleTitleLimited proteolysis of tyrosine hydroxylase by Ca(2+)-activated neutral protease (calpain).lld:pubmed
pubmed-article:1681901pubmed:affiliationRadioisotope Center Medical Division, Nagoya University School of Medicine, Japan.lld:pubmed
pubmed-article:1681901pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1681901pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1681901lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1681901lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1681901lld:pubmed